Evolution of Salvage Radical Prostatectomy from Open to Robotic and Further to Retzius Sparing Surgery.
Retzius-sparing
open radical prostatectomy
robotic radical prostatectomy
salvage prostatectomy
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
30 Dec 2021
30 Dec 2021
Historique:
received:
16
11
2021
revised:
16
12
2021
accepted:
28
12
2021
entrez:
11
1
2022
pubmed:
12
1
2022
medline:
12
1
2022
Statut:
epublish
Résumé
Salvage radical prostatectomy (sRP) has evolved from open to minimally invasive approaches. sRP can be offered to patients with local recurrence to improve biochemical recurrence (BCR)-free and overall survival. We evaluate oncological outcome and continence after retropubic (RRP), conventional (cRARP), and Retzius-sparing robotic (rsRARP) surgery. A total of 53 patients undergoing sRP between 2010 and 2020 were included. Follow-up included oncological outcome and continence. sRP was done as RRP ( Over the years, sRP has shifted from open to laparoscopic/robotic surgery. RARP shows good oncological and functional outcome. rsRARP ensures direct vision on the rectum during preparation and can therefore increase safety and surgeon's confidence, especially in the salvage setting.
Identifiants
pubmed: 35011942
pii: jcm11010202
doi: 10.3390/jcm11010202
pmc: PMC8745561
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur Urol Focus. 2021 Aug 21;:
pubmed: 34429272
Cancer. 2014 Feb 15;120(4):507-12
pubmed: 24496867
J Urol. 1995 Sep;154(3):1103-9
pubmed: 7543608
J Urol. 2010 Jul;184(1):136-42
pubmed: 20478594
Prostate. 1983;4(5):473-85
pubmed: 6889192
Curr Oncol. 2021 Jul 29;28(4):2881-2892
pubmed: 34436018
Lancet. 2016 Sep 10;388(10049):1057-1066
pubmed: 27474375
Urology. 2003 Dec 29;62 Suppl 1:69-78
pubmed: 14747044
Eur Urol. 2017 Nov;72(5):677-685
pubmed: 28483330
Eur Urol. 2014 Feb;65(2):314-5
pubmed: 23993160
J Urol. 2005 Feb;173(2):373-9
pubmed: 15643174
Eur Urol. 2010 Mar;57(3):437-43
pubmed: 19303197
Eur Urol. 2020 Dec;78(6):885-892
pubmed: 32461073
J Urol. 1998 Dec;160(6 Pt 2):2418-24
pubmed: 9817395
Urol Oncol. 2021 May;39(5):296.e21-296.e29
pubmed: 33436329
J Urol. 2021 Oct 25;:101097JU0000000000002295
pubmed: 34694141
J Urol. 1979 Feb;121(2):198-200
pubmed: 423333
Urol Clin North Am. 2021 Feb;48(1):11-23
pubmed: 33218585
Eur Urol. 2010 Sep;58(3):457-61
pubmed: 20566236
J Urol. 2010 Jan;183(1):133-7
pubmed: 19913249
Eur Urol. 2012 Apr;61(4):679-85
pubmed: 22206800
J Urol. 2021 Mar;205(3):780-790
pubmed: 33086025
J Clin Oncol. 2010 Mar 1;28(7):1117-23
pubmed: 20124165
Adv Urol. 2012;2012:702412
pubmed: 22924039
J Urol. 2000 Jun;163(6):1643-9
pubmed: 10799152
Can J Urol. 2016 Jun;23(3):8271-7
pubmed: 27347619
Eur Urol. 2011 Sep;60(3):411-2
pubmed: 21247684
Eur Urol. 2021 Feb;79(2):243-262
pubmed: 33172724
J Endourol. 2011 Jun;25(6):1013-9
pubmed: 21568696
Eur Urol. 2014 Apr;65(4):675-80
pubmed: 24035631
Lancet Oncol. 2018 Aug;19(8):1051-1060
pubmed: 30017351
BJU Int. 2020 Jan;125(1):8-16
pubmed: 31373142
J Urol. 2019 Oct;202(4):725-731
pubmed: 31075058
BJU Int. 2018 Nov;122(5):837-844
pubmed: 30126045
Urology. 2003 Apr;61(4):699-702
pubmed: 12670546
J Urol. 2013 Feb;189(2):507-13
pubmed: 23000849
BJU Int. 2013 Aug;112(3):322-9
pubmed: 23356910
Eur Urol. 2012 May;61(5):961-71
pubmed: 22280856
Prostate. 2021 Dec;81(16):1428-1434
pubmed: 34570379
BJU Int. 2021 Jul;128(1):12-20
pubmed: 33686742